Phio Pharmaceuticals Corp.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -60.6% | -60.6% | -52.8% |
| FY2022 | -105.9% | -105.9% | -89.6% |
| FY2023 | -140.1% | -140.1% | -115.6% |
| FY2024 | -151.4% | -151.4% | -124.6% |
| FY2025 | -43.2% | -43.2% | -40.5% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -60.6% | -60.6% | -52.8% |
| FY2022 | -105.9% | -105.9% | -89.6% |
| FY2023 | -140.1% | -140.1% | -115.6% |
| FY2024 | -151.4% | -151.4% | -124.6% |
| FY2025 | -43.2% | -43.2% | -40.5% |